At Caucus on International Narcotic Control meeting, Klobuchar discussed the importance of staying ahead of criminals creating new synthetic drugs
Earlier this year, Klobuchar introduced legislation to make it easier to prosecute the sale and distribution of “analogue” drugs, which are illegal synthetic substances that are substantially similar to already listed illegal drugs
WASHINGTON, D.C. – U.S. Senator Amy Klobuchar highlighted her work to fight dangerous synthetic drugs at a meeting of the International Narcotic Control Caucus. Klobuchar discussed with witnesses, including the Deputy Director of the Office of National Drug Control Policy, Michael Botticelli, the importance in staying ahead of criminals creating new synthetic drugs. Earlier this year, Klobuchar introduced bipartisan legislation to make it easier to prosecute the sale and distribution of new synthetic drugs that are illegal “analogues” – or substantially similar to currently illegal drugs. In addition, Klobuchar has passed legislation outlawing harmful synthetic substances such as 2C-E, which led to the death of a Minnesota teenager and hospitalized several others.
“Synthetic drugs wreak havoc on the lives of families,” said Klobuchar. “This bill will make it easier to crack down on these harmful substances, and I will continue to work to keep these dangerous drugs from endangering the lives of teenagers and families every day.”
Klobuchar’s bill amends the Controlled Substances Act to require consideration of a number of factors when determining whether a controlled substance analogue was intended for human consumption, including the marketing, advertising, and labeling of a substance, and its known use. The bill also provides that evidence that a substance was not marketed, advertised or labeled for human consumption, by itself, is not sufficient to establish that the substance was not intended for human consumption.